Skip to main content
Premium Trial:

Request an Annual Quote

IBM Joins SNP Consortium, Second Tech Co. Member

Premium

C

hicago--The SNP Consortium announced that IBM has joined its group effort to create a public database of gene markers to enhance understanding of the biological basis for disease. IBM joins 10 major pharmaceutical companies, the Wellcome Trust, and Motorola in the two-year, $50 million initiative to identify and analyze SNPs.

Founded last year, the consortium intends to identify a minimum of 300,000 and map at least 150,000 SNPs by April 2001. Since November, the group has deposited some 7,200 newly identified and characterized SNPs into public databases accessible through the internet, said the consortium.

Filed under

The Scan

Not Yet a Permanent One

NPR says the lack of a permanent Food and Drug Administration commissioner has "flummoxed" public health officials.

Unfair Targeting

Technology Review writes that a new report says the US has been unfairly targeting Chinese and Chinese-American individuals in economic espionage cases.

Limited Rapid Testing

The New York Times wonders why rapid tests for COVID-19 are not widely available in the US.

Genome Research Papers on IPAFinder, Structural Variant Expression Effects, Single-Cell RNA-Seq Markers

In Genome Research this week: IPAFinder method to detect intronic polyadenylation, influence of structural variants on gene expression, and more.